Please use this identifier to cite or link to this item:
|Type:||Artigo de periódico|
|Title:||Pharmaceutical Equivalence Study Of 10 Mg Memantine Hydrochloride Tablets Of Apsen Farmacêutica S.a. (alois®) Versus Lundbeck Brasil Ltda. (ebix®) [estudo De Equivalência Farmacêutica De Cloridrato De Memantina Comprimidos De 10 Mg De Apsen Farmacêutica S.a. (alois®) Versus Lundbeck Brasil Ltda. (ebix®)]|
|Abstract:||Memantine HCI belongs to the class of antiviral medications(1), used for the treatment of Alzheimer's and Parkinson's diseases with a mechanism of action distinct from currently available drugs. Memantine HCI presents neuroprotective properties, blocking calcium channels activated by NMDA receptor agonists (N-Methyl-D-Aspartate). Among other applications, treatment for glaucoma and Influenza can be cited. This study presents the validation of the analytical method for the assay of 10 mg coated tablets of memantine HCI made by Apsen Farmacêutica S.A., employing the technique of GC (Gas Chromatography). It also shows the Pharmaceutical Equivalence of this medication against a reference product nominated by ANVISA (Brazilian Government Food and Drug Agency). © Copyright Moreira Jr. Editora. Todos os direitos reservados.|
|Appears in Collections:||Unicamp - Artigos e Outros Documentos|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.